trending Market Intelligence /marketintelligence/en/news-insights/trending/97lsa6gsz9tysqmlfjc5yq2 content esgSubNav
In This List

Indian regulator approves sale of Kraft Heinz India brands to Cadila, Zydus

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Earnings forecasts for US banks; corporate deleveraging; LatAm currency gains

Blog

Insight Weekly: M&A slows down; climate tops proxy season; private equity pours into blockchain


Indian regulator approves sale of Kraft Heinz India brands to Cadila, Zydus

The Competition Commission of India has approved the sale of Kraft Heinz Co.'s Indian business, including a portfolio of several brands, to Indian pharmaceutical company Cadila Healthcare Ltd. and its consumer products division Zydus Wellness Ltd.

The competition watchdog announced the decision in a Dec. 11 tweet, without disclosing further details.

Zydus and Kraft Heinz confirmed the 45.95 billion Indian rupee deal in separate announcements in October.

Heinz India Pvt. Ltd.'s brands include children's drink Complan, energy drink Glucon D, Nycil talcum powder and Sampriti butter.

As of Dec. 11, US$1 was equivalent to 72.30 Indian rupees.